|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2025―Feb―02 |
Health Disparities Among Migrant Workers During COVID-19 in Maldives |
Abdulla Sanah, Ghassan Salibi, Nikolaos Tzenios |
2 |
[GO] |
2024―Dec―20 |
The impact of different brands of covid-19 vaccination on public health outcomes: analyzing the effectiveness and side effects of these vaccines among ksmu students and their perspectives towards covid vaccinations |
Angle Tang Ngiik Ling |
3 |
[GO] |
2024―Dec―20 |
The impact of different brands of covid-19 vaccination on public health outcomes: analyzing the effectiveness and side effects of these vaccines among ksmu students and their perspectives towards covid vaccinations |
Angle Tang Ngiik Ling, Ghassan Salibi |
4 |
[GO] |
2024―May―23 |
Role Of Acute Vascular Distress Syndrome In The Development Of Multisystem Inflammatory Syndrome In Sars-Cov-2 And Modern Views On The Research And Treatment Of Critical Coronavirus |
Irina Vasilieva, Maria Vasilieva, Ilie Vasiliev |
5 |
[GO] |
2023―Apr―23 |
GLOBAL SYSTEMATIC REVIEW AND META-ANALYSIS OF FOETAL AND MATERNAL OUTCOMES IN PREGNANT WOMEN INFECTED WITH COVID-19 |
Poh Omasyarifa Binti Jamal, Puneet Puneet |
6 |
[GO] |
2023―Mar―04 |
Intralipid blocks the entry of the SARS-Cov2/COVID/19 virus into cells by maintaining receptor a leucine-rich repeat containing 15 (LRRC15), an angiotensin-converting enzyme 2 receptor competitor. |
Irina Vasilieva, Maria Vasilieva, Ilie Vasiliev |
7 |
[GO] |
2023―Mar―04 |
Intralipid blocks the entry of the SARS-Cov2/COVID/19 virus into cells by maintaining receptor a leucine-rich repeat containing 15 (LRRC15), an angiotensin-converting enzyme 2 receptor competitor. |
Irina Vasilieva, Maria Vasilieva, Ilie Vasiliev |
8 |
[GO] |
2023―Feb―09 |
Better Strategies For Coronavirus (COVID-19) Vaccination |
Nikolaos Tzenios, Mohamad Chahine, Mary Tazanios |